Screener
Protagonist Therapeutics PTGX Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Protagonist Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Protagonist Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091123
FAQ
- What is Protagonist Therapeutics's asset turnover?
- Protagonist Therapeutics (PTGX) reported asset turnover of 0.4× in Q2 2026.
- How has Protagonist Therapeutics's asset turnover changed year-over-year?
- Protagonist Therapeutics's asset turnover increased by 12.0% year-over-year, from 0.3× to 0.4×.
- What is the long-term trend for Protagonist Therapeutics's asset turnover?
- Over 4 years (2021 to 2025), Protagonist Therapeutics's asset turnover has grown at a -5.4% compound annual growth rate (CAGR), from 0.1× to 0.1×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Protagonist Therapeutics's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude